Earlier this year, the Infection Innovation Consortium: iiCON and partners launched the first human challenge trial for a new vaccine for pneumococcal disease – marking a key milestone in a collaborative global project that is offering new hope in the fight against the disease. Professor Stephen Gordon, Director of Experimental Medicine at iiCON, is leading […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!